Published in Life Sci on January 01, 1990
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Genetic screening: marvel or menace? Science (1984) 1.78
Genetic counseling for beta-thalassemia trait following health screening in a health maintenance organization: comparison of programmed and conventional counseling. Am J Hum Genet (1981) 1.44
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood. Am J Hum Genet (1979) 1.39
Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health (1995) 1.35
Newborn screening for hemoglobinopathies in New York State: experience of physicians and parents of affected children. J Pediatr (1982) 1.35
Prenatal screening for hemoglobinopathies. II. Evaluation of counseling. Am J Hum Genet (1991) 1.13
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods. Am J Hum Genet (1984) 1.13
Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer (1989) 1.13
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. Ann Intern Med (1971) 1.12
Induction of -globin synthesis in the -thalassaemia of Ferrara. Nat New Biol (1972) 1.08
Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol (1981) 1.07
Erythroid colony formation from human fetal liver. Proc Natl Acad Sci U S A (1978) 1.06
Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet (1996) 1.02
Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy. Am J Hum Genet (1991) 1.01
Newborn sickle cell screening. Benefits and burdens realized. Am J Dis Child (1983) 0.96
Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait. Ann Intern Med (1986) 0.94
Hemoglobin synthesis in cultures of hepatic erythroid cells from the human fetus. Proc Natl Acad Sci U S A (1979) 0.94
Family issues in a psychoeducation group for women with a BRCA mutation. Clin Genet (2002) 0.91
Separation of malarial parasites according to age by density gradient centrifugation. J Lab Clin Med (1967) 0.89
Protein synthesis in the maturing reticulocyte. J Biol Chem (1967) 0.89
Distinction between two types of beta-thalassaemia by inducibility of the cell-free synthesis of beta-chains by nonthalassaemic soluble fraction. Nat New Biol (1972) 0.89
Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens. Leuk Res (1987) 0.88
The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet (1991) 0.86
Protein synthesis in reticulocytes maturing in vivo. Nature (1965) 0.86
Newborn screening for sicle-cell disease. Benefits and burdens. N Y State J Med (1978) 0.86
Carrier screening for cystic fibrosis: test acceptance and one year follow-up. Am J Med Genet (1997) 0.86
An adult homozygous for persistent fetal hemoglobin. Ann Intern Med (1970) 0.85
Erythroleukemia manifesting delta beta-thalassemia. Hemoglobin (1983) 0.85
Pathogenesis of deficient serum alpha1-antitrypsin in the type ZZ homozygote. Biochem Genet (1974) 0.85
Alveolar cell carcinoma in identical twins. Similarity in time of onset, histochemistry, and site of metastasis. Ann Intern Med (1977) 0.85
Linkage between the MN- and Hb beta-loci? Hum Hered (1972) 0.84
Sickle hemoglobin: a specific radioimmunoassay. Blood (1974) 0.84
Toward providing parents the option of avoiding the birth of the first child with Cooley's anemia: response to hemoglobinopathy screening and counseling during pregnancy. Ann N Y Acad Sci (1985) 0.84
Regulation of K562 cell transferrin receptors by exogenous iron. J Cell Physiol (1985) 0.84
The diagnosis of beta-thalassemia trait: a review. Am J Hematol (1976) 0.84
A Lepore hemoglobin in a Rumanian family. Hum Hered (1969) 0.84
Hemoglobin S-C disease presenting as acute cor pulmonale. Am Rev Respir Dis (1968) 0.83
Incorporation of screening and genetic counseling for beta-thalassemia trait into primary health care: effects on knowledge and attitudes. Birth Defects Orig Artic Ser (1982) 0.83
Acquired hemoglobin H disease in idiopathic myelofibrosis. Am J Hematol (1979) 0.82
K562 human erythroleukemia cells demonstrate commitment. Blood (1985) 0.81
K562 human leukemia cell passages differ in embryonic globin gene expression. Leuk Res (1984) 0.81
Solubilization of a reticulocyte ribosomal fraction responsible for the decline in ribosomal activity with cell maturation. Arch Biochem Biophys (1971) 0.81
Induction of megakaryocytic characteristics in human leukemic cell line K562: polyploidy, inducers, and secretion of mitogenic activity. J Biol Regul Homeost Agents (1988) 0.80
Oncogene expression in neurofibromatosis. Ann N Y Acad Sci (1986) 0.80
Predicting immediate outcome of genetic counseling following screening. Soc Biol (1979) 0.80
The linkage relationships of the haemoglobin beta, delta and alpha loci with 34 genetic marker systems. Ann Hum Genet (1977) 0.80
High resolution analysis of hemoglobins: polyacrylamide isoelectric focusing. Biochem Med (1972) 0.79
Telomere-related components are coordinately synthesized during human T-lymphocyte activation. Leuk Res (1999) 0.79
Hemin preferentially stimulates synthesis of alpha-globin in K562 human erythroleukemia cells. Blood (1982) 0.79
Human lymphocyte telomerase is genetically regulated. Genes Chromosomes Cancer (1998) 0.79
Serm alpha-antitrypsin types: elastase inhibition versus trypsin inhibition. Hum Hered (1974) 0.78
Tumor suppressor genes and inherited predisposition to malignancy. Semin Oncol (1989) 0.78
Demonstration of commitment by K562 human erythroleukemia cells. Prog Clin Biol Res (1985) 0.77
Serum antitrypsin synthesis by the isolated perfused rat liver. Proc Soc Exp Biol Med (1975) 0.77
Induction of HL60 cell differentiation by tiazofurin and its analogues: characterization and efficacy. Blood (1991) 0.77
Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives? Lancet (1970) 0.77
Disappearance of ribosomes and polyribosomes during in vivo erythroid maturation. Nature (1967) 0.77
Regulation of the activity of heme degradative enzymes in K562 erythroleukemic cells: induction by thymidine. Exp Hematol (1987) 0.76
Sickle beta-thalassemia: identical twins differing in severity implicate nongenetic factors influencing course. Am J Hematol (1976) 0.76
Prenatal screening for hemoglobinopathies. Am J Hum Genet (1991) 0.75
Confusion about breast-cancer screening. N Engl J Med (1997) 0.75
Characteristics of the antitrypsin activity of human serum. J Clin Pathol (1973) 0.75
K562 human erythroleukemia cell variants resistant to growth inhibition by butyrate have deficient histone acetylation. Am J Hum Genet (1984) 0.75
Enhanced polyribosome recovery from reticulocytes using heparin. Exp Cell Res (1967) 0.75
Deleterious mutations of both BRCA1 and BRCA2 in three siblings. Genet Test (1998) 0.75
American society of human genetics (ASHG) committee reports. Am J Hum Genet (1987) 0.75
Genetic testing for breast-ovarian cancer susceptibility: a regional trial. Genet Test (1998) 0.75
Genetics for the cardiologist. Part I: mendelian inheritance. Mod Concepts Cardiovasc Dis (1978) 0.75
Long survival in sickle-cell disease. Lancet (1973) 0.75
Single-cell analysis of the relationship among transferrin receptors, proliferation, and cell cycle phase in K562 cells. Cytometry (1985) 0.75
Genetic considerations in neuromuscular diseases. Adv Neurol (1977) 0.75
Erythropoiesis in vitro: enhancement by neuraminidase. Blood (1981) 0.75
Sickle cell trait/hereditary persistence of fetal hemoglobin trait. Misdiagnosis as sickle cell anemia by newborn screening. Am J Dis Child (1979) 0.75
Trypsin enhances erythropoiesis in vitro. J Lab Clin Med (1980) 0.75
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Genet Med (2001) 0.75
Oncogene expression in myelopoiesis. Int J Cell Cloning (1987) 0.75
Textural differences between AA and SS blood specimens as detected by image analysis. Cytometry (1994) 0.75
Erythroid induction of K562 human leukemia cells: enhancement by purines. Arch Biochem Biophys (1985) 0.75
Genetic screening: whose responsibility? JAMA (1976) 0.75
What you should know about chromosome analysis. Alaska Med (1969) 0.75
Erythroid differentiation of K562 cells: mixed colonies as an index of delayed expression of commitment. Exp Hematol (1987) 0.75
Hypersplenic thrombocytopenia in sickle cell-bata thalassemia. Am J Med Sci (1972) 0.75
Assessment of evaluation of hospitalized pediatric patients with genetic disorders. Clin Pediatr (Phila) (1981) 0.75
Drug-sensitive hemoglobinopathies. N Engl J Med (1973) 0.75
Induction of hemoglobin synthesis in K562 cells by carbon dioxide deficiency. Int J Cell Cloning (1987) 0.75
Letter: Family history-taking. J Med Educ (1976) 0.75
Genetic counseling in medical practice. Alaska Med (1969) 0.75
No limits to genetic inquiry. Hastings Cent Rep (1988) 0.75
Familial hearing loss associated with branchial fistulas. Pediatrics (1969) 0.75
The contribution of red cell morphology to the diagnosis of beta-thalassemia trait. Blood Cells (1986) 0.75
Genetics for the cardiologist. Part II: Chromosomal and polygenic inheritance and genetic counseling. Mod Concepts Cardiovasc Dis (1978) 0.75
K562 cell erythroid differentiation: requirement for a factor in fetal bovine serum. Exp Hematol (1985) 0.75